+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Frontotemporal Dementia - Pipeline Insight, 2025 - Product Thumbnail Image

Frontotemporal Dementia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Multiple Sclerosis - Pipeline Insight, 2025 - Product Thumbnail Image

Multiple Sclerosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Solid Tumor Cancer Treatment Market Report 2026 - Product Thumbnail Image

Solid Tumor Cancer Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Personalized Medicine Market Report 2026 - Product Thumbnail Image

Personalized Medicine Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Cell Therapy Technologies Market Report 2026 - Product Thumbnail Image

Cell Therapy Technologies Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Antisense & RNAi Therapeutics Market Report 2026 - Product Thumbnail Image

Antisense & RNAi Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
DNA Repair Drugs Market Report 2026 - Product Thumbnail Image

DNA Repair Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
RNA Interference- Pipeline Insight, 2025 - Product Thumbnail Image

RNA Interference- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 204 Pages
  • Global
From
From
From
From
From
Neurologic Disorders Therapeutics Market 2024-2028 - Product Thumbnail Image

Neurologic Disorders Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 150 Pages
  • Global
From
Loading Indicator